Mpox Vaccine Interest Survey Prioritization and Data Flow: Maricopa County, Arizona, July-August 2022.
Am J Public Health
; 113(5): 504-508, 2023 05.
Article
in En
| MEDLINE
| ID: mdl-36893362
ABSTRACT
With increasing mpox cases in Maricopa County, Arizona, the county's health department launched a survey on July 11, 2022, to gather eligibility and contact data and provide clinic information to those interested in JYNNEOS as postexposure prophylaxis (PEP) or expanded postexposure prophylaxis(PEP++). Survey data were matched to case and vaccination data. Overall, 343 of the 513 respondents (66.9%) who reported close contact with an mpox case patient received PEP and 1712 of the 3379 respondents (50.7%) who were unsure of their contact status received PEP++. This outreach intervention connected potential close contacts unknown to MCDPH with PEP or PEP++. (Am J Public Health. 2023;113(5)504-508. https//doi.org/10.2105/AJPH.2023.307224).
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Smallpox Vaccine
/
Vaccines
/
Mpox (monkeypox)
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Am J Public Health
Year:
2023
Document type:
Article
Affiliation country:
Azerbaijan